Given as a daily pill, INS1007 is a selective, reversible inhibitor of dipeptidyl peptidase 1 (DPP1), an enzyme that plays a role in the development of neutrophils in the bone marrow. (Pixabay). Share Facebook Twitter LinkedIn Email Print. In 2016, Insmed bet …
See Original Article

The government’s decision to bring forward the ban on petrol, diesel and hybrid cars to 2035 has drawn mixed reactions ahead of Glasgow’s COP26 summit. Previously, the government had planned to phase out petrol, diesel and hybrid cars by 2040 as part …
See Original Article

Accounting quality is the most underestimated investment risk in India. Nearly half the stocks which were in the BSE 500 ten years ago, have exited the
See Original Article

SEOUL (Reuters) – Hyundai Motor (005380.KS) plans to gradually suspend its South Korean factories starting on Tuesday, as a virus outbreak in China has disrupted supplies of a vehicle component, Yonhap News Agency said. Hyundai’s South Korean …
See Original Article

David Neal, the CEO of Australia’s Future Fund, will leave the A$168.1 billion ($112.9 billion) sovereign wealth fund at the end of February to become chief executive of IFM Investors, a Melbourne-based money manager best known for its infrastructure …
See Original Article